Drug Detail

Information about GDC-0973 + GDC-0068

Generic Name
IND	GDC-0973 + GDC-0068
Brand Name (US)
Manufacturer	Genentech
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	Oncogenic Signal Path Based
Strategy	Block related tumor signal paths
Drug Category	Akt inhibitor + MEK inhibitor

Links
Trials of this drug
	A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors

Trial results